ID   CRLF1_HUMAN             Reviewed;         422 AA.
AC   O75462; Q9UHH5;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   07-APR-2021, entry version 183.
DE   RecName: Full=Cytokine receptor-like factor 1;
DE   AltName: Full=Cytokine-like factor 1;
DE            Short=CLF-1;
DE   AltName: Full=ZcytoR5;
DE   Flags: Precursor;
GN   Name=CRLF1; ORFNames=UNQ288/PRO327;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RC   TISSUE=Fetal lung;
RX   PubMed=9686600;
RA   Elson G.C.A., Graber P., Losberger C., Herren S., Gretener D., Menoud L.N.,
RA   Wells T.N.C., Kosco-Vilbois M.H., Gauchat J.-F.;
RT   "Cytokine-like factor-1, a novel soluble protein, shares homology with
RT   members of the cytokine type I receptor family.";
RL   J. Immunol. 161:1371-1379(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Magrangeas F., Jacques Y., Minvielle S.;
RT   "Cloning and expression of a novel soluble protein containing hematopoietic
RT   cytokine receptor domains.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Lok S., Presnell S.R., Jelmberg A.C., Gilbert T., Whitmore T.E.,
RA   Foster D.C., Adams R.L., Lehner J.M., O'Hara P.J.;
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 38-52.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [7]
RP   INTERACTION WITH CLCF1 AND CNTFR.
RX   PubMed=10966616; DOI=10.1038/78765;
RA   Elson G.C.A., Lelievre E., Guillet C., Chevalier S., Plun-Favreau H.,
RA   Froger J., Suard I., de Coignac A.B., Delneste Y., Bonnefoy J.-Y.,
RA   Gauchat J.-F., Gascan H.;
RT   "CLF associates with CLC to form a functional heteromeric ligand for the
RT   CNTF receptor complex.";
RL   Nat. Neurosci. 3:867-872(2000).
RN   [8]
RP   INTERACTION WITH CLCF1; CNTFR AND SORL1.
RX   PubMed=26858303; DOI=10.1128/mcb.00917-15;
RA   Larsen J.V., Kristensen A.M., Pallesen L.T., Bauer J., Vaegter C.B.,
RA   Nielsen M.S., Madsen P., Petersen C.M.;
RT   "Cytokine-like factor 1, an essential facilitator of cardiotrophin-like
RT   cytokine:ciliary neurotrophic factor receptor alpha signaling and sorLA-
RT   mediated turnover.";
RL   Mol. Cell. Biol. 36:1272-1286(2016).
RN   [9]
RP   VARIANTS CISS1 HIS-81 AND ARG-374.
RX   PubMed=12509788; DOI=10.1086/346120;
RA   Knappskog P.M., Majewski J., Livneh A., Nilsen P.T.E., Bringsli J.S.,
RA   Ott J., Boman H.;
RT   "Cold-induced sweating syndrome is caused by mutations in the CRLF1 gene.";
RL   Am. J. Hum. Genet. 72:375-383(2003).
RN   [10]
RP   VARIANT CISS1 CYS-284.
RX   PubMed=16952376; DOI=10.1016/j.jns.2006.07.001;
RA   Hahn A.F., Jones D.L., Knappskog P.M., Boman H., McLeod J.G.;
RT   "Cold-induced sweating syndrome: a report of two cases and demonstration of
RT   genetic heterogeneity.";
RL   J. Neurol. Sci. 250:62-70(2006).
RN   [11]
RP   VARIANT CISS1 GLY-76.
RX   PubMed=17436251; DOI=10.1086/513608;
RA   Dagoneau N., Bellais S., Blanchet P., Sarda P., Al-Gazali L.I.,
RA   Di Rocco M., Huber C., Djouadi F., Le Goff C., Munnich A.,
RA   Cormier-Daire V.;
RT   "Mutations in cytokine receptor-like factor 1 (CRLF1) account for both
RT   Crisponi and cold-induced sweating syndromes.";
RL   Am. J. Hum. Genet. 80:966-970(2007).
RN   [12]
RP   VARIANT CISS1 GLY-76.
RX   PubMed=17436252; DOI=10.1086/516843;
RA   Crisponi L., Crisponi G., Meloni A., Toliat M.R., Nurnberg G., Usala G.,
RA   Uda M., Masala M., Hohne W., Becker C., Marongiu M., Chiappe F., Kleta R.,
RA   Rauch A., Wollnik B., Strasser F., Reese T., Jakobs C., Kurlemann G.,
RA   Cao A., Nurnberg P., Rutsch F.;
RT   "Crisponi syndrome is caused by mutations in the CRLF1 gene and is allelic
RT   to cold-induced sweating syndrome type 1.";
RL   Am. J. Hum. Genet. 80:971-981(2007).
RN   [13]
RP   VARIANTS CISS1 ASP-75; ILE-113 AND PRO-114.
RX   PubMed=21326283; DOI=10.1038/ejhg.2010.253;
RA   Herholz J., Meloni A., Marongiu M., Chiappe F., Deiana M., Herrero C.R.,
RA   Zampino G., Hamamy H., Zalloum Y., Waaler P.E., Crisponi G., Crisponi L.,
RA   Rutsch F.;
RT   "Differential secretion of the mutated protein is a major component
RT   affecting phenotypic severity in CRLF1-associated disorders.";
RL   Eur. J. Hum. Genet. 19:525-533(2011).
RN   [14]
RP   VARIANT CISS1 LEU-138.
RX   PubMed=23026229; DOI=10.1016/j.braindev.2012.08.011;
RA   Tuysuz B., Kasapcopur O., Yalcinkaya C., Isik Hasiloglu Z., Knappskog P.M.,
RA   Boman H.;
RT   "Multiple small hyperintense lesions in the subcortical white matter on
RT   cranial MR images in two Turkish brothers with cold-induced sweating
RT   syndrome caused by a novel missense mutation in the CRLF1 gene.";
RL   Brain Dev. 35:596-601(2013).
RN   [15]
RP   VARIANTS CISS1 PRO-74; PRO-145; CYS-216; SER-268; PRO-312 AND CYS-340.
RX   PubMed=24488861; DOI=10.1002/humu.22522;
RA   Piras R., Chiappe F., Torraca I.L., Buers I., Usala G., Angius A.,
RA   Akin M.A., Basel-Vanagaite L., Benedicenti F., Chiodin E., El Assy O.,
RA   Feingold-Zadok M., Guibert J., Kamien B., Kasapkara C.S., Kilic E.,
RA   Boduroglu K., Kurtoglu S., Manzur A.Y., Onal E.E., Paderi E., Roche C.H.,
RA   Tumer L., Unal S., Utine G.E., Zanda G., Zankl A., Zampino G., Crisponi G.,
RA   Crisponi L., Rutsch F.;
RT   "Expanding the mutational spectrum of CRLF1 in Crisponi/CISS1 syndrome.";
RL   Hum. Mutat. 35:424-433(2014).
CC   -!- FUNCTION: In complex with CLCF1, forms a heterodimeric neurotropic
CC       cytokine that plays a crucial role during neuronal development
CC       (Probable). May also play a regulatory role in the immune system.
CC       {ECO:0000305|PubMed:26858303}.
CC   -!- SUBUNIT: Forms covalent di- and tetramers. Forms a heteromeric complex
CC       with cardiotrophin-like cytokine CLCF1/CLC; the CRLF1-CLCF1 complex is
CC       a ligand for the ciliary neurotrophic factor receptor/CNTFR
CC       (PubMed:9686600, PubMed:26858303). The CRLF1-CLCF1 heterodimer binds
CC       SORL1 (via N-terminal ectodomain); within this complex, the interaction
CC       is mediated predominantly by the CRLF1 moiety (PubMed:26858303). The
CC       tripartite signaling complex formed by CRLF1, CLCF1 and CNTFR also
CC       binds SORL1 (PubMed:26858303). {ECO:0000269|PubMed:26858303,
CC       ECO:0000269|PubMed:9686600}.
CC   -!- INTERACTION:
CC       O75462; Q8NEV9: IL27; NbExp=2; IntAct=EBI-15587902, EBI-15887997;
CC       O75462; Q92673: SORL1; NbExp=3; IntAct=EBI-15587902, EBI-1171329;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:9686600}.
CC   -!- TISSUE SPECIFICITY: Highest levels of expression observed in spleen,
CC       thymus, lymph node, appendix, bone marrow, stomach, placenta, heart,
CC       thyroid and ovary. Strongly expressed also in fetal lung.
CC       {ECO:0000269|PubMed:9686600}.
CC   -!- INDUCTION: Up-regulated in fibroblast primary cell cultures under
CC       stimulation by IFNG/IFN-gamma, TNF and IL6/interleukin-6.
CC       {ECO:0000269|PubMed:9686600}.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding.
CC   -!- DISEASE: Crisponi/Cold-induced sweating syndrome 1 (CISS1)
CC       [MIM:272430]: An autosomal recessive disorder characterized by profuse
CC       sweating induced by cool surroundings (temperatures of 7 to 18 degrees
CC       Celsius). Patients manifest, in the neonatal period, orofacial weakness
CC       with impaired sucking and swallowing, resulting in poor feeding.
CC       Affected infants show a tendency to startle, with contractions of the
CC       facial muscles in response to tactile stimuli or during crying,
CC       trismus, abundant salivation, and opisthotonus. These features are
CC       referred to as Crisponi syndrome and can result in early death in
CC       infancy. Patients who survive into childhood have hyperhidrosis, mainly
CC       of the upper body, in response to cold temperatures, and sweat very
CC       little with heat. Additional abnormalities include a high-arched
CC       palate, nasal voice, depressed nasal bridge, inability to fully extend
CC       the elbows and kyphoscoliosis. {ECO:0000269|PubMed:12509788,
CC       ECO:0000269|PubMed:16952376, ECO:0000269|PubMed:17436251,
CC       ECO:0000269|PubMed:17436252, ECO:0000269|PubMed:21326283,
CC       ECO:0000269|PubMed:23026229, ECO:0000269|PubMed:24488861}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 3
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF059293; AAC28335.1; -; mRNA.
DR   EMBL; AF073515; AAD39681.1; -; mRNA.
DR   EMBL; AF178684; AAD54385.1; -; mRNA.
DR   EMBL; AY358291; AAQ88658.1; -; mRNA.
DR   EMBL; BC044634; AAH44634.1; -; mRNA.
DR   CCDS; CCDS32962.1; -.
DR   RefSeq; NP_004741.1; NM_004750.4.
DR   SMR; O75462; -.
DR   BioGRID; 114670; 5.
DR   DIP; DIP-61205N; -.
DR   IntAct; O75462; 7.
DR   STRING; 9606.ENSP00000376188; -.
DR   GlyConnect; 1167; 3 N-Linked glycans (1 site).
DR   GlyGen; O75462; 6 sites.
DR   iPTMnet; O75462; -.
DR   PhosphoSitePlus; O75462; -.
DR   BioMuta; CRLF1; -.
DR   EPD; O75462; -.
DR   jPOST; O75462; -.
DR   MassIVE; O75462; -.
DR   MaxQB; O75462; -.
DR   PaxDb; O75462; -.
DR   PeptideAtlas; O75462; -.
DR   PRIDE; O75462; -.
DR   ProteomicsDB; 50025; -.
DR   Antibodypedia; 28115; 236 antibodies.
DR   DNASU; 9244; -.
DR   Ensembl; ENST00000392386; ENSP00000376188; ENSG00000006016.
DR   GeneID; 9244; -.
DR   KEGG; hsa:9244; -.
DR   UCSC; uc010ebt.3; human.
DR   CTD; 9244; -.
DR   DisGeNET; 9244; -.
DR   GeneCards; CRLF1; -.
DR   GeneReviews; CRLF1; -.
DR   HGNC; HGNC:2364; CRLF1.
DR   HPA; ENSG00000006016; Low tissue specificity.
DR   MalaCards; CRLF1; -.
DR   MIM; 272430; phenotype.
DR   MIM; 604237; gene.
DR   neXtProt; NX_O75462; -.
DR   OpenTargets; ENSG00000006016; -.
DR   Orphanet; 157820; Cold-induced sweating syndrome.
DR   Orphanet; 1545; Crisponi syndrome.
DR   Orphanet; 930; Idiopathic achalasia.
DR   PharmGKB; PA26882; -.
DR   VEuPathDB; HostDB:ENSG00000006016.10; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00940000156569; -.
DR   HOGENOM; CLU_017892_0_0_1; -.
DR   InParanoid; O75462; -.
DR   OMA; MSCDSKS; -.
DR   OrthoDB; 144839at2759; -.
DR   PhylomeDB; O75462; -.
DR   TreeFam; TF106501; -.
DR   BRENDA; 1.1.1.105; 2681.
DR   PathwayCommons; O75462; -.
DR   Reactome; R-HSA-6788467; IL-6-type cytokine receptor ligand interactions.
DR   Reactome; R-HSA-9020956; Interleukin-27 signaling.
DR   SignaLink; O75462; -.
DR   SIGNOR; O75462; -.
DR   BioGRID-ORCS; 9244; 8 hits in 987 CRISPR screens.
DR   GeneWiki; CRLF1; -.
DR   GenomeRNAi; 9244; -.
DR   Pharos; O75462; Tbio.
DR   PRO; PR:O75462; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; O75462; protein.
DR   Bgee; ENSG00000006016; Expressed in right coronary artery and 189 other tissues.
DR   ExpressionAtlas; O75462; baseline and differential.
DR   Genevisible; O75462; HS.
DR   GO; GO:0097058; C:CRLF-CLCF1 complex; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0019955; F:cytokine binding; IPI:HGNC-UCL.
DR   GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0070106; P:interleukin-27-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:2000672; P:negative regulation of motor neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IDA:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:BHF-UCL.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IDA:BHF-UCL.
DR   GO; GO:0001657; P:ureteric bud development; IEA:Ensembl.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR015152; Growth/epo_recpt_lig-bind.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   Pfam; PF09067; EpoR_lig-bind; 1.
DR   Pfam; PF00041; fn3; 1.
DR   SMART; SM00060; FN3; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 2.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disease variant; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Phosphoprotein; Receptor; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL          1..37
FT                   /evidence="ECO:0000269|PubMed:15340161"
FT   CHAIN           38..422
FT                   /note="Cytokine receptor-like factor 1"
FT                   /id="PRO_0000011039"
FT   DOMAIN          38..131
FT                   /note="Ig-like C2-type"
FT   DOMAIN          137..232
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          237..341
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   MOTIF           327..331
FT                   /note="WSXWS motif"
FT   MOD_RES         219
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JM58"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        104
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        168
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        292
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        382
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        143..153
FT                   /evidence="ECO:0000250"
FT   DISULFID        184..195
FT                   /evidence="ECO:0000250"
FT   VARIANT         74
FT                   /note="L -> P (in CISS1; dbSNP:rs1295488778)"
FT                   /evidence="ECO:0000269|PubMed:24488861"
FT                   /id="VAR_070817"
FT   VARIANT         75
FT                   /note="Y -> D (in CISS1)"
FT                   /evidence="ECO:0000269|PubMed:21326283"
FT                   /id="VAR_070818"
FT   VARIANT         76
FT                   /note="W -> G (in CISS1; dbSNP:rs137853143)"
FT                   /evidence="ECO:0000269|PubMed:17436251,
FT                   ECO:0000269|PubMed:17436252"
FT                   /id="VAR_033113"
FT   VARIANT         81
FT                   /note="R -> H (in CISS1; dbSNP:rs104894670)"
FT                   /evidence="ECO:0000269|PubMed:12509788"
FT                   /id="VAR_017865"
FT   VARIANT         113
FT                   /note="N -> I (in CISS1; together with P-114)"
FT                   /evidence="ECO:0000269|PubMed:21326283"
FT                   /id="VAR_070819"
FT   VARIANT         114
FT                   /note="L -> P (in CISS1; together with I-113;
FT                   dbSNP:rs774359694)"
FT                   /evidence="ECO:0000269|PubMed:21326283"
FT                   /id="VAR_070820"
FT   VARIANT         138
FT                   /note="P -> L (in CISS1; dbSNP:rs137853930)"
FT                   /evidence="ECO:0000269|PubMed:23026229"
FT                   /id="VAR_070821"
FT   VARIANT         145
FT                   /note="S -> P (in CISS1)"
FT                   /evidence="ECO:0000269|PubMed:24488861"
FT                   /id="VAR_070822"
FT   VARIANT         176
FT                   /note="R -> K (in dbSNP:rs11672248)"
FT                   /id="VAR_028355"
FT   VARIANT         216
FT                   /note="R -> C (in CISS1; dbSNP:rs556029569)"
FT                   /evidence="ECO:0000269|PubMed:24488861"
FT                   /id="VAR_070823"
FT   VARIANT         268
FT                   /note="F -> S (in CISS1; dbSNP:rs761982168)"
FT                   /evidence="ECO:0000269|PubMed:24488861"
FT                   /id="VAR_070824"
FT   VARIANT         284
FT                   /note="W -> C (in CISS1; dbSNP:rs137853927)"
FT                   /evidence="ECO:0000269|PubMed:16952376"
FT                   /id="VAR_070825"
FT   VARIANT         312
FT                   /note="R -> P (in CISS1; dbSNP:rs137853933)"
FT                   /evidence="ECO:0000269|PubMed:24488861"
FT                   /id="VAR_070826"
FT   VARIANT         340
FT                   /note="R -> C (in CISS1; dbSNP:rs771459625)"
FT                   /evidence="ECO:0000269|PubMed:24488861"
FT                   /id="VAR_070827"
FT   VARIANT         374
FT                   /note="L -> R (in CISS1; dbSNP:rs104894668)"
FT                   /evidence="ECO:0000269|PubMed:12509788"
FT                   /id="VAR_017866"
FT   CONFLICT        240
FT                   /note="D -> E (in Ref. 3; AAD54385)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   422 AA;  46302 MW;  AD9DEFCB01B84228 CRC64;
     MPAGRRGPAA QSARRPPPLL PLLLLLCVLG APRAGSGAHT AVISPQDPTL LIGSSLLATC
     SVHGDPPGAT AEGLYWTLNG RRLPPELSRV LNASTLALAL ANLNGSRQRS GDNLVCHARD
     GSILAGSCLY VGLPPEKPVN ISCWSKNMKD LTCRWTPGAH GETFLHTNYS LKYKLRWYGQ
     DNTCEEYHTV GPHSCHIPKD LALFTPYEIW VEATNRLGSA RSDVLTLDIL DVVTTDPPPD
     VHVSRVGGLE DQLSVRWVSP PALKDFLFQA KYQIRYRVED SVDWKVVDDV SNQTSCRLAG
     LKPGTVYFVQ VRCNPFGIYG SKKAGIWSEW SHPTAASTPR SERPGPGGGA CEPRGGEPSS
     GPVRRELKQF LGWLKKHAYC SNLSFRLYDQ WRAWMQKSHK TRNQDEGILP SGRRGTARGP
     AR
//
